Non-hypoproteinemic hypertrophic gastropathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:329883K29.6
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Non-hypoproteinemic hypertrophic gastropathy is a rare condition in which the lining of the stomach becomes abnormally thick and enlarged, forming giant folds. Unlike a related condition called Ménétrier disease (hypoproteinemic hypertrophic gastropathy), this form does not cause significant protein loss through the stomach wall. This means that blood protein levels remain normal or near-normal, which is an important distinguishing feature. The thickened stomach folds can cause a range of digestive symptoms including upper abdominal pain, nausea, vomiting, and a feeling of fullness after eating only small amounts of food. Some patients may also experience acid reflux or mild bleeding from the stomach lining. The exact cause of this condition is not fully understood, but it is thought to involve abnormal growth signals in the cells lining the stomach. Treatment is mainly focused on managing symptoms. Acid-reducing medications such as proton pump inhibitors are commonly used to help control stomach acid and reduce discomfort. In some cases, if symptoms are severe or complications arise, surgical removal of part or all of the stomach may be considered. Regular monitoring with endoscopy (a camera examination of the stomach) is important because thickened stomach tissue may carry a slightly increased risk of developing stomach cancer over time. The condition is chronic, meaning it tends to persist, but many patients can manage their symptoms effectively with ongoing medical care.

Also known as:

Key symptoms:

Upper abdominal pain or discomfortNauseaVomitingFeeling full quickly after eatingLoss of appetiteAcid reflux or heartburnBloatingWeight lossMild stomach bleedingEnlarged or giant stomach folds seen on endoscopyIndigestion

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Non-hypoproteinemic hypertrophic gastropathy.

View clinical trials →

No actively recruiting trials found for Non-hypoproteinemic hypertrophic gastropathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Non-hypoproteinemic hypertrophic gastropathy community →

No specialists are currently listed for Non-hypoproteinemic hypertrophic gastropathy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Non-hypoproteinemic hypertrophic gastropathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Non-hypoproteinemic hypertrophic gastropathyForum →

No community posts yet. Be the first to share your experience with Non-hypoproteinemic hypertrophic gastropathy.

Start the conversation →

Latest news about Non-hypoproteinemic hypertrophic gastropathy

No recent news articles for Non-hypoproteinemic hypertrophic gastropathy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the likely cause of my thickened stomach lining, and could it be related to an infection?,How often should I have endoscopy exams to monitor for any changes or cancer risk?,Are there specific foods I should avoid to help manage my symptoms?,What medications do you recommend, and what are their potential side effects with long-term use?,At what point would surgery be considered, and what would that involve?,Should I be concerned about nutritional deficiencies, and do I need any supplements?,Are there any clinical trials or new treatments being studied for this condition?

Common questions about Non-hypoproteinemic hypertrophic gastropathy

What is Non-hypoproteinemic hypertrophic gastropathy?

Non-hypoproteinemic hypertrophic gastropathy is a rare condition in which the lining of the stomach becomes abnormally thick and enlarged, forming giant folds. Unlike a related condition called Ménétrier disease (hypoproteinemic hypertrophic gastropathy), this form does not cause significant protein loss through the stomach wall. This means that blood protein levels remain normal or near-normal, which is an important distinguishing feature. The thickened stomach folds can cause a range of digestive symptoms including upper abdominal pain, nausea, vomiting, and a feeling of fullness after eati

How is Non-hypoproteinemic hypertrophic gastropathy inherited?

Non-hypoproteinemic hypertrophic gastropathy follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Non-hypoproteinemic hypertrophic gastropathy typically begin?

Typical onset of Non-hypoproteinemic hypertrophic gastropathy is adult. Age of onset can vary across affected individuals.